These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36459708)

  • 1. Molecular identification, phylogeny and antifungal susceptibilities of dematiaceous fungi isolated from human keratomycosis.
    Mythili A; Shobana CS; Krizsán K; Hassan AS; Sangeetha AB; Homa M; Papp T; Alharbi RA; Othaim A; Baazeem A; Selvam KP; Kannaiyan M; Vágvölgyi C; Kredics L; Manikandan P
    J Infect Public Health; 2023 Jan; 16(1):25-33. PubMed ID: 36459708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs.
    Shobana CS; Mythili A; Homa M; Galgóczy L; Priya R; Babu Singh YR; Panneerselvam K; Vágvölgyi C; Kredics L; Narendran V; Manikandan P
    J Mycol Med; 2015 Mar; 25(1):44-9. PubMed ID: 25541256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
    Xu Y; Pang GR; Zhao DQ; Gao CW; Zhou LT; Sun ST; Wang BL; Chen ZJ
    Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the synergistic antifungal activity of everolimus and antifungal drugs against dematiaceous fungi.
    An L; Jia G; Tan J; Yang L; Wang Y; Li L
    Front Cell Infect Microbiol; 2023; 13():1131416. PubMed ID: 36909734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
    Voelter-Ratson K; Monod M; Unger L; Spiess BM; Pot SA
    Vet Ophthalmol; 2014 Jul; 17 Suppl 1():31-6. PubMed ID: 23910390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia.
    da Cunha KC; Sutton DA; Fothergill AW; Gené J; Cano J; Madrid H; Hoog Sd; Crous PW; Guarro J
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):168-74. PubMed ID: 23558007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous fungal endophthalmitis: an analysis of isolates and susceptibilities to antifungal agents over a 20-year period (1990-2010).
    Silva RA; Sridhar J; Miller D; Wykoff CC; Flynn HW
    Am J Ophthalmol; 2015 Feb; 159(2):257-64.e1. PubMed ID: 25449001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN;
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi.
    González GM
    Med Mycol; 2009 Feb; 47(1):71-6. PubMed ID: 19101837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the expanding spectrum of sertraline against uncommon fungal pathogens.
    Villanueva-Lozano H; González GM; Espinosa-Mora JE; Bodden-Mendoza BA; Andrade A; Martínez-Reséndez MF; Treviño-Rangel RJ
    J Infect Chemother; 2020 Mar; 26(3):309-311. PubMed ID: 31678053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
    Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
    Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
    Ozdemir HG; Oz Y; Ilkit M; Kiraz N
    Med Mycol; 2012 Feb; 50(2):130-5. PubMed ID: 21599550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations.
    Halliday CL; Chen SC; Kidd SE; van Hal S; Chapman B; Heath CH; Lee A; Kennedy KJ; Daveson K; Sorrell TC; Morrissey CO; Marriott DJ; Slavin MA
    Int J Antimicrob Agents; 2016 Oct; 48(4):453-8. PubMed ID: 27562696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
    Marco F; Pfaller MA; Messer SA; Jones RN
    Med Mycol; 1998 Dec; 36(6):433-6. PubMed ID: 10206756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of phenylmercuric acetate against ocular pathogenic fungi.
    Xu Y; Zhao D; Gao C; Zhou L; Pang G; Sun S
    J Antimicrob Chemother; 2012 Aug; 67(8):1941-4. PubMed ID: 22514262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fungal Keratitis Associated with Curvularia lunata: First Case Report from Türkiye].
    Öner SZ; Küçükakın Yaka S; Akçaoğlu T; Vural C; Yılmaz U; Ergin Ç
    Mikrobiyol Bul; 2023 Oct; 57(4):690-697. PubMed ID: 37885397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Dematiaceous and Hyaline Fungi Causing Keratitis in a Tertiary Care Centre From North India.
    Ghosh A; Kaur H; Gupta A; Singh S; Rudramurthy SM; Gupta S; Chakrabarti A
    Cornea; 2020 Jul; 39(7):868-876. PubMed ID: 32398423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular identification and antifungal susceptibility of Curvularia australiensis, C. hawaiiensis and C. spicifera isolated from human eye infections.
    Krizsán K; Tóth E; Nagy LG; Galgóczy L; Manikandan P; Chandrasekaran M; Kadaikunnan S; Alharbi NS; Vágvölgyi C; Papp T
    Mycoses; 2015 Oct; 58(10):603-9. PubMed ID: 26345164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin.
    Wildfeuer A; Seidl HP; Paule I; Haberreiter A
    Mycoses; 1998; 41(7-8):309-19. PubMed ID: 9861837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.